EVE-112 Vaginal Ring

Alternative Name: Etonogestrel (ENG) + Ethinyl Estradiol (EE) Vaginal Ring; EVE112

Description: A vaginal ring expected to be a bioequivalent to NuvaRing with a different release profile.

Product Details

User: Female

Hormonal: Yes

Delivery Method: Vaginal Ring

Duration Type: Short-acting

Dose: Etonogestrel: 5mg, ethinyl estradiol: 0.85mg

Active Pharmaceutical Ingredient (API):
  • etonogestrel
  • ethinyl estradiol

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: Evestra, Inc., Gedeon Richter Plc.

Project Phase: Pre-Clinical and Clinical Development

Development Stage: Phase III

Active Development: Yes

Status Details:
  • Ongoing phase III clinical trial.

Additional Information

References:

Vertical Tabs

Print